Johnson & Johnson price target raised to $250 from $222 at TD Cowen

9 hours ago 1

TipRanks

Fri, January 23, 2026 astatine 8:45 AM CST 1 min read

TD Cowen expert Joshua Jennings raised the firm’s price target connected Johnson & Johnson to $250 from $222 and keeps a Buy standing connected the shares. Johnson & Johnson reported beardown Q4 results with $24.6B successful revenue, surpassing consensus, and its archetypal 2026 guidance is apt to assistance Street gross and EPS estimates, the expert tells investors successful a probe note. Momentum successful the Pharma and Devices franchises from 2H25 is expected to proceed done 2026 and beyond, the steadfast says.

Claim 50% Off TipRanks Premium

Unlock hedge fund-level information and almighty investing tools for smarter, sharper decisions
Stay up of the marketplace with the latest quality and investigation and maximize your portfolio's potential

Published archetypal connected TheFly – the eventual root for real-time, market-moving breaking fiscal news. Try Now>>

See the apical stocks recommended by analysts >>

Read More connected JNJ:

Disclaimer & DisclosureReport an Issue